LD 1007 requires healthcare professionals in Maine to provide specific information during informed consent for drug-induced abortions. It mandates that providers inform patients about the potential for reversal if they change their mind (noting time sensitivity), and that initial studies suggest no increased maternal mortality or birth defect risks from reversal. Providers must also give patients a written statement with a website and helpline number (to be updated annually by the Department of Health) for information on abortion pill reversal services. This bill directly affects women seeking drug-induced abortions and their healthcare providers in Maine.
LD 886 regulates medication abortions in Maine by requiring in-person consultations and prescriptions from licensed health care professionals. It prohibits purchasing or obtaining medication abortion drugs online and mandates that providers explain the process, expected experiences, physical/emotional/spiritual risks, and potential reversal options to patients. The bill directly affects individuals seeking medication abortions and the health care professionals who provide them. These provisions aim to standardize access and information for medication abortions under Maine law.
LD 887 requires health care providers to be physically present during chemical abortions, including examining the patient, scheduling a follow-up within 7 days, and providing a labeled catch kit and medical waste bag for proper disposal. It makes manufacturers of abortion drugs liable for the proper disposal of the drugs and cleanup if endocrine disruptors (chemicals interfering with hormones) are found in wastewater, imposing $20,000 civil penalties for violations. The bill directly affects providers prescribing abortion drugs, manufacturers of these drugs, and patients receiving chemical abortions. Exceptions apply only for life-threatening medical emergencies. This bill does not change the legal status of abortion but adds specific procedural and disposal requirements.
LD 253 repeals Maine Revised Statutes, Title 22, section 3196, which previously required the MaineCare program (Maine's Medicaid program) to cover abortion services for enrollees. This bill removes the mandate that the Department of Health and Human Services fund abortion services, including state funding when federal Medicaid does not cover them. As a result, MaineCare would no longer be required to cover abortion services for its members. The bill directly affects MaineCare enrollees who previously had access to this coverage under the repealed law.
LD 682 requires healthcare providers to report abortion procedures to Maine's Department of Health and Human Services, including patient demographics like race, marital status, and education level, as specified by national public health standards. It changes the standard for abortions after fetal viability to allow them only when medically necessary to preserve the mother's life or health, or when a fetus has a "lethal fetal anomaly" (a condition likely to cause the baby's death within three months after birth). The bill reinstates criminal penalties for unlicensed individuals performing abortions or assisting unlicensed providers, and clarifies that only licensed physicians, physician assistants, or advanced practice nurses may perform abortions. These changes directly affect abortion providers, patients receiving care, and state health data collection.
LD 1899 creates a new deduction for Maine state income tax on medical and dental expenses paid by taxpayers or their spouses/dependents. It allows a deduction for expenses that qualify under federal tax law (Internal Revenue Code), even if they don't meet the federal threshold or weren't claimed on federal returns. The deduction applies to expenses not covered by insurance and is effective for tax years beginning January 1, 2026. This directly affects individual Maine taxpayers who pay for healthcare costs, expanding their state tax relief beyond federal requirements.
LD 1712 amends Maine's Paid Family and Medical Leave program to adjust requirements for employees and employers. It requires employees to give reasonable notice before taking leave and allows employers to deny leave based on specific, defined hardships (such as having fewer than 15 employees, a summer labor shortage, or more than 25% of staff already on leave), without review of such decisions. The bill also revises benefit calculations to replace 65% of average weekly wage (with 90% replacement for wages up to 50% of the state average and 66% for higher wages), shortens application deadlines for benefits (with waivers for good cause), and modifies premium payments so employers deduct 50% of the cost from employee wages while covering the remaining 50%.
LD 544 exempts sales of cannabis for medical use from Maine's sales tax, creating tax parity with prescription medicines. The bill amends Maine's tax code to include medical cannabis sales (after January 1, 2026) under the existing exemption for prescription medicines sold by doctors. It directly affects patients certified for medical cannabis use under Maine's Medical Use of Cannabis Act and providers selling to them. This policy change removes a sales tax burden currently applied to medical cannabis, aligning its tax treatment with other prescribed medicines. The exemption applies only to cannabis sold with a medical provider's certification, not recreational sales.
This bill repeals Maine's mandatory paid family and medical leave program, making participation voluntary instead. It limits the program to employers with 50 or more employees and requires the Department of Labor to refund all contributions made under the previous mandatory system to both employers and employees by June 2026. Unappropriated funds from the leave program must be transferred to the state's general fund by June 30, 2026. The changes take effect retroactively to October 25, 2023.
LD 1333 updates Maine's Paid Family and Medical Leave program to clarify eligibility and administration. It requires employees to have worked for an employer for at least 120 days to qualify, shortens the deadline for filing leave applications from 90 to 30 days after leave begins, and adjusts employer contribution rules: companies with 15+ workers can deduct 50% of premiums from employee wages and send 100% to the fund, while smaller employers send 50%. The bill also specifies that leave under this program runs concurrently with federal FMLA, and defines "self-employed" to include small business owners with fewer than 15 employees. These changes directly affect Maine workers seeking leave and their employers managing contributions.